We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ALVO icon
26
Alvotech
ALVO
$1.88B
$1.88B $5.28 0.76%
ANIP icon
27
ANI Pharmaceuticals
ANIP
$1.62B
$1.62B $70.68 1.09%
ETON icon
28
Eton Pharmaceutcials
ETON
$1.62B
$1.62B $56.74 1.97%
PAHC icon
29
Phibro Animal Health
PAHC
$1.45B
$1.45B $35.74 2.3%
XERS icon
30
Xeris Biopharma Holdings
XERS
$1.35B
$1.35B $7.43 3.13%
HROW icon
31
Harrow
HROW
$1.3B
$1.3B $34.64 5.3%
CRON
32
Cronos Group
CRON
$1.15B
$1.15B $3.13 0.95%
PCRX icon
33
Pacira BioSciences
PCRX
$1.02B
$1.02B $25.50 1.35%
AMPH icon
34
Amphastar Pharmaceuticals
AMPH
$1.01B
$1.01B $23.63 0.38%
GLAS
35
Glass House Brands
GLAS
$758M
$758M $8.04 0.75%
COLL icon
36
Collegium Pharmaceutical
COLL
$741M
$741M $22.77 0.65%
IRWD icon
37
Ironwood Pharmaceuticals
IRWD
$666M
$666M $4.03 1.51%
EVO icon
38
Evotec
EVO
$615M
$615M $1.73 2.26%
AQST icon
39
Aquestive Therapeutics
AQST
$601M
$601M $4.79 4.01%
TLRY icon
40
Tilray
TLRY
$554M
$554M $4.03 2.66%
EOLS icon
41
Evolus
EOLS
$520M
$520M $7.88 0.38%
KMDA icon
42
Kamada
KMDA
$457M
$457M $7.92 0.88%
CGC
43
Canopy Growth
CGC
$413M
$413M $0.9202 1.05%
BIOA
44
BioAge Labs
BIOA
$383M
$383M $8.34 3.58%
TKNO icon
45
Alpha Teknova
TKNO
$362M
$362M $6.74 2.46%
EBS icon
46
Emergent Biosolutions
EBS
$317M
$317M $6.19 5.45%
ANIK icon
47
Anika Therapeutics
ANIK
$280M
$280M $20.95 0.19%
AKBA icon
48
Akebia Therapeutics
AKBA
$268M
$268M $0.9661 2.07%
ACB
49
Aurora Cannabis
ACB
$234M
$234M $3.69 1.07%
CRDL
50
Cardiol Therapeutics
CRDL
$231M
$231M $1.98 0%
1
2
3 4

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 81 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $335B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $58.3B, Teva Pharmaceuticals (TEVA) at $42.9B and Haleon (HLN) at $40.3B.

Among institutional investors, Trulieve Cannabis Corp (TRLV) drew the most net new fund positions in Q2 2026: 121 funds opened new positions, taking total fund holders up 119 (1,983%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.